/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Salix Pharmaceuticals Ltd. (SLXP) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 26.71\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n -0.26\n\n (-0.96%)\n\n \n\n \n\n \n\n \n\n Volume: 69.27 k\n\n \n\n \n\n\n\n 10:08 AM EST Feb 10, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
January 28,2010
\n \n
Close: \n 29.91\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
March 05,2009
\n \n
Close: \n 6.14\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
26.71
\n 		\n\n \n \n \n
Change $
\n \n 0.26\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 0.96%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
26.71
\n 		\n \n \n \n\n
Bid Size
200
\n 		\n \n \n \n
Ask
26.74
\n\n 		\n \n \n \n
Ask Size
200
\n
\n \n \n \n
Open
26.89
\n 		\n \n \n \n
High
27.20
\n 		\n\n \n \n \n
Low
26.69
\n 		\n \n\n \n \n
Prev Close
26.97
\n
\n \n\n \n \n
Last Trade
10:08
\n 		\n \n \n \n
Volume
69.27 k
\n 		\n \n \n \n
\n
52 Wk Hi
29.91
\n 		\n\n \n \n \n
52 Wk Low
6.14
\n
\n \n\n \n \n
Market Cap
1.32 b
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
49,344,406
\n 		\n \n \n \n
EPS (TTM)
-0.98
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
Nasdaq Global Select (NGS)
\n
\n
\n
\n
\n
\n \n
Exchange
NGS
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Salix Pharmaceuticals Ltd.\n\n \n\n  (SLXP) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for SLXP\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 23, 2009
\n\n \n\n\n\n
4:31 PM\n\n\n\n Suits Commenced Against Maker of Prescription Cleansing Drug - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 10, 2009
\n\n \n\n\n\n
9:31 AM\n\n\n\n Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of the Pending Rifaximin NDA in the Treatment of Non-Constipation Irritable Bowel Syndrome - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 24, 2009
\n\n \n\n\n\n
7:00 AM\n\n\n\n Salix Pharmaceuticals to Present at Piper Jaffray Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 23, 2009
\n\n \n\n\n\n
11:50 AM\n\n\n\n Salix Pharmaceuticals, Ltd. Completes Sale of 6.325 Million Shares of Common Stock - Business Wire
6:25 AM\n\n\n\n The Fortune Financial Coverage of New Alliance Bancshares Inc., Men's Wearhouse Inc., Microsoft Corp., Hercules Offshore Inc., News Corp. and Salix Pharmaceuticals Ltd - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 18, 2009
\n\n \n\n\n\n
9:09 AM\n\n\n\n Salix Pharmaceuticals, Ltd. Announces Pricing of a Public Offering of Common Stock - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 11, 2009
\n\n \n\n\n\n
6:54 AM\n\n\n\n AnalystChoice.com Provides Analytical Coverage on BMS, TKC, DTG, ACH, CTB and SLXP - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 09, 2009
\n\n \n\n\n\n
4:01 PM\n\n\n\n Salix Pharmaceuticals Reports 3Q2009 Results - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 04, 2009
\n\n \n\n\n\n
7:01 AM\n\n\n\n Salix Pharmaceuticals to Host Analyst Day on November 18 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 03, 2009
\n\n \n\n\n\n
10:10 AM\n\n\n\n FDA Approves New Salix Product Exclusively in Catalent's Zydis(R) Fast Dissolve Technology - Business Wire
10:09 AM\n\n\n\n Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 02, 2009
\n\n \n\n\n\n
7:00 AM\n\n\n\n Salix Pharmaceuticals Reviews American Association for the Study of Liver Diseases Annual Meeting - Business Wire
5:37 AM\n\n\n\n PLAB, SLXP, ABAT, TECD, HGSI and PLUG Receiving Professional Financial Coverage from RothmanResearch.com - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Oct 26, 2009
\n\n \n\n\n\n
3:19 PM\n\n\n\n Lupin Q2 net profit rises 39% - Hindu Business Line
11:21 AM\n\n\n\n Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting - Marketwire
11:00 AM\n\n\n\n Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting - Business Wire
7:00 AM\n\n\n\n Salix Pharmaceuticals Announces 3Q2009 Financial Results Conference Call and Webcast - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Oct 05, 2009
\n\n \n\n\n\n
10:57 AM\n\n\n\n Lupin Licenses US Rights for Proprietary Bioadhesive Technology for Rifaximin to Salix Pharmaceuticals - PR Newswire
7:00 AM\n\n\n\n Salix Pharmaceuticals Acquires U.S. Right to Lupin's Proprietary Bioadhesive Technology for Extended Release Rifaximin Product - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Sep 28, 2009
\n\n \n\n\n\n
11:15 AM\n\n\n\n Salix Pharmaceuticals to Present at JMP Securities Conference - Business Wire
\n\n More News for SLXP >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");